KR19990087100A - 항병원성 펩타이드와 그 구성물 - Google Patents

항병원성 펩타이드와 그 구성물

Info

Publication number
KR19990087100A
KR19990087100A KR1019980706488A KR19980706488A KR19990087100A KR 19990087100 A KR19990087100 A KR 19990087100A KR 1019980706488 A KR1019980706488 A KR 1019980706488A KR 19980706488 A KR19980706488 A KR 19980706488A KR 19990087100 A KR19990087100 A KR 19990087100A
Authority
KR
South Korea
Prior art keywords
leu
lys
ile
peptide
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019980706488A
Other languages
English (en)
Korean (ko)
Inventor
예히엘 샤이
지브 오렌
Original Assignee
야코브 코헨, 데이비드 미렐맨
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 야코브 코헨, 데이비드 미렐맨, 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 filed Critical 야코브 코헨, 데이비드 미렐맨
Publication of KR19990087100A publication Critical patent/KR19990087100A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019980706488A 1996-02-22 1997-02-20 항병원성 펩타이드와 그 구성물 Withdrawn KR19990087100A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL117223 1996-02-22
IL11722396A IL117223A0 (en) 1996-02-22 1996-02-22 Antipathogenic polypeptides and compositions comprising them

Publications (1)

Publication Number Publication Date
KR19990087100A true KR19990087100A (ko) 1999-12-15

Family

ID=11068576

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019980706488A Withdrawn KR19990087100A (ko) 1996-02-22 1997-02-20 항병원성 펩타이드와 그 구성물
KR1019997007477A Withdrawn KR20000071187A (ko) 1996-02-22 1998-02-19 항병원성 합성 펩타이드와 그 구성물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019997007477A Withdrawn KR20000071187A (ko) 1996-02-22 1998-02-19 항병원성 합성 펩타이드와 그 구성물

Country Status (13)

Country Link
US (1) US6172038B1 (https=)
EP (1) EP0904291A2 (https=)
JP (1) JP2000506128A (https=)
KR (2) KR19990087100A (https=)
CN (1) CN1216549A (https=)
AU (1) AU730069B2 (https=)
BR (1) BR9707691A (https=)
CA (1) CA2247025A1 (https=)
CZ (1) CZ264398A3 (https=)
EA (1) EA199800754A1 (https=)
IL (2) IL117223A0 (https=)
NZ (1) NZ331219A (https=)
WO (1) WO1997031019A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281204A1 (en) * 1997-02-20 1998-08-27 Yeda Research And Development Co., Ltd. Antipathogenic synthetic peptides and compositions comprising them
US7067109B1 (en) 1998-07-13 2006-06-27 Board Of Regents, The University Of Texas System Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids
US6818213B1 (en) * 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
PT1783222E (pt) 1998-10-23 2012-07-26 Kirin Amgen Inc Péptidos diméricos de trombopoietina que simulam a ligação ao receptor mpl e têm actividade trombopoiética
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
GB0005703D0 (en) 2000-03-09 2000-05-03 Alpharma As Compounds
IL139720A0 (en) * 2000-11-16 2002-02-10 Yeda Res & Dev Diastereomeric peptides and pharmaceutical compositions comprising them
AU2004246909B2 (en) * 2003-06-19 2010-08-19 Yeda Research & Development Co. Ltd. Antimicrobial and anticancer lipopeptides
WO2006010057A2 (en) 2004-07-08 2006-01-26 Amgen Inc. Therapeutic peptides
EA011879B1 (ru) 2004-09-24 2009-06-30 Эмджин Инк. МОЛЕКУЛЫ С МОДИФИЦИРОВАННЫМ Fc ФРАГМЕНТОМ
JP4849642B2 (ja) * 2004-11-24 2012-01-11 ネオプロ ラブス， エルエルシー 状態を処置するための方法および組成物
WO2006128289A1 (en) * 2005-06-02 2006-12-07 University Of Manitoba Use of brevinin-2r in the treatment of cancer
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
WO2007074457A2 (en) * 2005-12-27 2007-07-05 Yeda Research And Development Co. Ltd. Histidine-containing diastereomeric peptides and uses thereof
JP2009526046A (ja) * 2006-02-10 2009-07-16 デルマゲン アクティエボラーグ 新規分子
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
WO2014038004A1 (ja) * 2012-09-05 2014-03-13 株式会社メニコン 薬物徐放性眼用レンズ及びその製造方法
JP6093528B2 (ja) * 2012-09-19 2017-03-08 株式会社ミルボン スクリーニング方法
US11103547B2 (en) 2016-02-04 2021-08-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods for disrupting biofilms
GB2557654A (en) * 2016-12-14 2018-06-27 Uea Enterprises Ltd Method for nucleic acid depletion
CN113528600A (zh) * 2021-07-08 2021-10-22 石河子大学 一种利用沙门氏菌诱导蝇蛆制备抗菌肽的方法
CN119607173A (zh) * 2025-01-07 2025-03-14 天津医科大学朱宪彝纪念医院(天津医科大学代谢病医院、天津代谢病防治中心) 小分子肽lklkll在制备降血糖产品中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258454A (en) * 1988-09-01 1993-11-02 Riso National Laboratory Peptide synthesis method and solid support for use in the method

Also Published As

Publication number Publication date
WO1997031019A2 (en) 1997-08-28
NZ331219A (en) 2000-04-28
IL125734A0 (en) 1999-04-11
AU1731997A (en) 1997-09-10
IL125734A (en) 2005-08-31
BR9707691A (pt) 1999-07-27
WO1997031019A3 (en) 1997-10-23
CN1216549A (zh) 1999-05-12
JP2000506128A (ja) 2000-05-23
KR20000071187A (ko) 2000-11-25
AU730069B2 (en) 2001-02-22
CZ264398A3 (cs) 1999-01-13
CA2247025A1 (en) 1997-08-28
IL117223A0 (en) 1996-06-18
EA199800754A1 (ru) 1999-10-28
EP0904291A2 (en) 1999-03-31
US6172038B1 (en) 2001-01-09

Similar Documents

Publication Publication Date Title
US7001983B1 (en) Antipathogenic synthetic peptides and compositions comprising them
KR19990087100A (ko) 항병원성 펩타이드와 그 구성물
Oren et al. Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure− function study
Shai et al. Diastereomers of cytolysins, a novel class of potent antibacterial peptides
Shin et al. Effects of the hinge region of cecropin A (1–8)–magainin 2 (1–12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells
Zhu et al. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1
KR101345333B1 (ko) 라이신 및 트립토판 잔기가 ４번 반복된 신규한 항균 및 항진균 펩타이드 및 이의 용도
Oren et al. A comparative study on the structure and function of a cytolytic α‐helical peptide and its antimicrobial β‐sheet diastereomer
US7371720B2 (en) Cationic peptides of the phylloseptin family isolated from the skin secretion of Phyllomedusa hypochondrialis
André et al. Structure–activity relationship-based optimization of small temporin-SHf analogs with potent antibacterial activity
US7902327B2 (en) Dendrimeric peptides, pharmaceutical compositions and methods of using the same
Saido-Sakanaka et al. Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide
Andrä et al. Shortened amoebapore analogs with enhanced antibacterial and cytolytic activity
KR100438416B1 (ko) Ｃａ－ｍａ 펩타이드의 아미노산 중 하나 또는 그 이상을치환하여 ＋ 전극과 소수성 영역이 증가된 신규한펩타이드 및 그를 포함하는 약학적 조성물
Lim et al. The role of the central l-or d-Pro residue on structure and mode of action of a cell-selective α-helical IsCT-derived antimicrobial peptide
Kuhn-Nentwig et al. Cupiennin 1d*: the cytolytic activity depends on the hydrophobic N-terminus and is modulated by the polar C-terminus
KR100935031B1 (ko) 헬리코박터 파일로리균의 리보좀 단백질 ｌ１유래의 유사체펩타이드로부터 풀림구조를 절단한 양이온 증가 항생펩타이드 및 항균 및 항진균용 조성물
Won et al. Structure-activity relationships of antimicrobial peptides from the skin of Rana esculenta inhabiting in Korea
KR101601364B1 (ko) 용혈현상이 감소된 항생 펩타이드 제조방법
Son et al. Effects of C-terminal residues of 12-mer peptides on antibacterial efficacy and mechanism
KR101847051B1 (ko) 병원균에 대한 항생활성을 갖는 펩타이드 및 이를 포함하는 항생 펩타이드 조성물
KR101062793B1 (ko) 적조유발 생물에 항조류 활성을 가지는 적조 방제용 펩타이드, 그의 용도 및 이의 제조 방법
KR100811745B1 (ko) 세포투과성 펩타이드 Ｐｅｐ １으로부터 설계된 신규한항균 펩타이드 Ｐｅｐ 1 Ｋ 및 그의 용도
MXPA99007799A (en) Antipathogenic synthetic peptides and compositions comprising them
KR100229281B1 (ko) 항암 효과가 있는 새로운 합성 펩타이드

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19980820

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid